Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 505 IDR -1.94% Market Closed
Market Cap: 5.7T IDR

Pyridam Farma Tbk PT
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Pyridam Farma Tbk PT
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Pyridam Farma Tbk PT
IDX:PYFA
Total Equity
Rp732.9B
CAGR 3-Years
17%
CAGR 5-Years
39%
CAGR 10-Years
22%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Total Equity
Rp9.4T
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
8%
Kalbe Farma Tbk PT
IDX:KLBF
Total Equity
Rp23T
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
9%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Total Equity
Rp1.5T
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
5%
Soho Global Health Tbk PT
IDX:SOHO
Total Equity
Rp2.7T
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Total Equity
Rp3.2T
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
6%
No Stocks Found

Pyridam Farma Tbk PT
Glance View

Market Cap
5.7T IDR
Industry
Pharmaceuticals

PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.

PYFA Intrinsic Value
501.24 IDR
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Pyridam Farma Tbk PT's Total Equity?
Total Equity
732.9B IDR

Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Total Equity amounts to 732.9B IDR.

What is Pyridam Farma Tbk PT's Total Equity growth rate?
Total Equity CAGR 10Y
22%

Over the last year, the Total Equity growth was -39%. The average annual Total Equity growth rates for Pyridam Farma Tbk PT have been 17% over the past three years , 39% over the past five years , and 22% over the past ten years .

Back to Top